• Skip to main content
  • Skip to secondary menu

3V.org

Venture Capital Trends: Follow the Money

  • Market Reports
  • Sponsored Post
  • Contact
    • About

cell therapy

Achilles Therapeutics raises £100 million in oversubscribed Series B financing

September 3, 2019 By 3v.org Leave a Comment

Achilles Therapeutics (“Achilles”), a biopharmaceutical company developing personalised cancer immunotherapies, today announces it has closed a £100 million Series B financing led by incoming U.S. investor RA Capital Management, corner-stoned by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile … [Read more...] about Achilles Therapeutics raises £100 million in oversubscribed Series B financing

Copyright © 2018 3V.org